Quintiles Designated Strategic Partner by Roche Three-Year Agreement

Quintiles Transnational Corp. announced it has entered a partnership with Roche for clinical study management services. The two companies have signed a three-year preferred provider agreement, which will give Roche more flexibility and efficiency in the development of its product pipeline. Analysts regard the Roche pipeline as among the best in the pharmaceutical industry, with medications for diabetes, hepatitis, anemia, rheumatoid arthritis and cancer among those in development.

mysan.de

(http://www.mysan.de/article103748.html)